Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
for
Advanced Prostate Adenocarcinoma,
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: Male
Age: 18+
Code: NCT06173362
Phase2, Recruiting
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
for
Melanoma, Melanoma Stage III, Melanoma (Skin),
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06771544
Phase2, Recruiting
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05372640
Phase1, Recruiting
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
for
Unresectable Melanoma, Metastatic Melanoma,
Location: New York NY, Miami FL, Pittsburgh PA, Orlando FL,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT05361174
Phase1, Phase2, Recruiting
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
for
Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03295227
Phase1, Recruiting
Interested in new multiple myeloma trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Mineola NY, New York NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05422794
Phase1, Recruiting
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
for
Large B-Cell Lymphoma With IRF4 Rearrangement,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06834373
Phase2, Recruiting
Limited-duration Teclistamab
for
Myeloma Multiple
Location: New York NY, Philadelphia PA, Iowa City IA,
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT05932680
Phase2, Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
for
Heart Failure, Heart Failure NYHA Class II,
Location: Jacksonville FL, Tampa FL, Clearwater FL,
Sponsor: CVRx, Inc.
Sex: All
Age: 18+
Code: NCT07232030
Recruiting
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University
Sex: Female
Age: 18+
Code: NCT05741164
Phase2, Recruiting
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
for
Psoriasis Vulgaris, Topical Administration, Phase III
Location: New York NY
Sponsor: Psoriasis Research Institute of Guangzhou
Sex: All
Age: 18 - 70
Code: NCT07426120
Phase3, Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: Boston MA, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase3, Recruiting
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
for
FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers,
Location: New York NY, Durham NC, Rochester MN, Irvine CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18 - 70+
Code: NCT07322094
Phase1, Phase2, Recruiting
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
for
Cutaneous Melanoma, Cutaneous Melanoma, Stage III,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07148245
Recruiting
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
for
Heart Failure and Reduced Ejection Fraction,
Location: Marlton NJ
Sponsor: Impulse Dynamics
Sex: All
Age: 18+
Code: NCT07209098
Recruiting
Safety and Efficacy of ONT01 in Lupus
for
Lupus Nephritis (LN), Lupus Nephritis - WHO Class III,
Location: New York NY
Sponsor: Hospital for Special Surgery, New York
Sex: All
Age: 18+
Code: NCT07107659
Early_phase1, Recruiting
NORM-HF Pivotal Study
for
Heart Failure, NYHA Class III Heart Failure,
Location: Philadelphia PA, Jacksonville FL, Tampa FL,
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)
Sex: All
Age: 18+
Code: NCT07574593
Recruiting
HEME Home Transfusion Program
for
Leukemia, Myeloma, Myelodysplastic Syndromes,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06487247
Recruiting
PREcision MEDicine In Achalasia (PREMEDIA) - Cohort
for
Type III Achalasia,
Location: Boston MA, Charlotte NC, Gainesville FL, Cleveland OH,
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT07293689
Recruiting
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms